The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria
- PMID: 9835522
- PMCID: PMC106030
- DOI: 10.1128/AAC.42.12.3251
The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria
Abstract
The oxazolidinones represent a new class of antimicrobial agents which are active against multidrug-resistant staphylococci, streptococci, and enterococci. Previous studies have demonstrated that oxazolidinones inhibit bacterial translation in vitro at a step preceding elongation but after the charging of N-formylmethionine to the initiator tRNA molecule. The event that occurs between these two steps is termed initiation. Initiation of protein synthesis requires the simultaneous presence of N-formylmethionine-tRNA, the 30S ribosomal subunit, mRNA, GTP, and the initiation factors IF1, IF2, and IF3. An initiation complex assay measuring the binding of [3H]N-formylmethionyl-tRNA to ribosomes in response to mRNA binding was used in order to investigate the mechanism of oxazolidinone action. Linezolid inhibited initiation complex formation with either the 30S or the 70S ribosomal subunits from Escherichia coli. In addition, complex formation with Staphylococcus aureus 70S tight-couple ribosomes was inhibited by linezolid. Linezolid did not inhibit the independent binding of either mRNA or N-formylmethionyl-tRNA to E. coli 30S ribosomal subunits, nor did it prevent the formation of the IF2-N-formylmethionyl-tRNA binary complex. The results demonstrate that oxazolidinones inhibit the formation of the initiation complex in bacterial translation systems by preventing formation of the N-formylmethionyl-tRNA-ribosome-mRNA ternary complex.
Figures




Similar articles
-
Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes.Antimicrob Agents Chemother. 2002 Apr;46(4):1080-5. doi: 10.1128/AAC.46.4.1080-1085.2002. Antimicrob Agents Chemother. 2002. PMID: 11897593 Free PMC article.
-
Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions.Antimicrob Agents Chemother. 1997 Oct;41(10):2132-6. doi: 10.1128/AAC.41.10.2132. Antimicrob Agents Chemother. 1997. PMID: 9333037 Free PMC article.
-
Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center.J Mol Biol. 1999 Nov 19;294(1):93-101. doi: 10.1006/jmbi.1999.3247. J Mol Biol. 1999. PMID: 10556031
-
Initiation of mRNA translation in bacteria: structural and dynamic aspects.Cell Mol Life Sci. 2015 Nov;72(22):4341-67. doi: 10.1007/s00018-015-2010-3. Epub 2015 Aug 11. Cell Mol Life Sci. 2015. PMID: 26259514 Free PMC article. Review.
-
Oxazolidinones--a new class of broad-spectrum chemotherapeutics.Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):335-41. Ann Univ Mariae Curie Sklodowska Med. 2004. PMID: 16146103 Review.
Cited by
-
Linezolid Exerts Greater Bacterial Clearance but No Modification of Host Lung Gene Expression Profiling: A Mouse MRSA Pneumonia Model.PLoS One. 2013 Jun 27;8(6):e67994. doi: 10.1371/journal.pone.0067994. Print 2013. PLoS One. 2013. PMID: 23826353 Free PMC article.
-
Linezolid-induced pure red cell aplasia: a case report and literature review.J Int Med Res. 2018 Nov;46(11):4837-4844. doi: 10.1177/0300060518800126. Epub 2018 Oct 1. J Int Med Res. 2018. PMID: 30270705 Free PMC article. Review.
-
In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother. 2005 Jan;49(1):45-51. doi: 10.1128/AAC.49.1.45-51.2005. Antimicrob Agents Chemother. 2005. PMID: 15616274 Free PMC article.
-
In vitro Activity of Linezolid in Combination with Photodynamic Inactivation Against Staphylococcus aureus Biofilms.Avicenna J Med Biotechnol. 2017 Jan-Mar;9(1):44-48. Avicenna J Med Biotechnol. 2017. PMID: 28090280 Free PMC article.
-
Optimization and Antibacterial Evaluation of Novel 3-(5-Fluoropyridine-3-yl)-2-oxazolidinone Derivatives Containing a Pyrimidine Substituted Piperazine.Molecules. 2023 May 23;28(11):4267. doi: 10.3390/molecules28114267. Molecules. 2023. PMID: 37298744 Free PMC article.
References
-
- Brickner S J, Hutchinson D K, Barbachyn M R, Manninen P R, Ulanowicz D A, Garmon S A, Grega K C, Hendges S K, Toops D S, Zurenko G E, Ford C W. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. J Med Chem. 1996;39:673–679. - PubMed
-
- Burghardt H, Schimz K L, Muller M. On the target of a novel class of antibiotics, oxazolidinones, active against multidrug-resistant gram-positive bacteria. FEBS Lett. 1998;425:40–44. - PubMed
-
- Buysse J M, Demyan W F, Dunyak D S, Stapert D, Hamel J C, Ford C W. Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1996. Mutation of the AcrAB antibiotic efflux pump in Escherichia coli confers susceptibility to oxazolidinone antibiotics, abstr. C-42; p. 41.
-
- Eustice D C, Feldman P A, Slee A M. Mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis. Biochem Biophys Res Commun. 1988;150:965–971. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases